Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infusion Reactions”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Large-scale testing (Phase 3)Study completedNCT04175834
What this trial is testing

Comparing Risk and Severity of IRRs in Patients Premedicated With Cetirizine vs. Diphenhydramine Prior to Ocrelizumab

Who this might be right for
Multiple SclerosisInfusion Reaction
Providence Health & Services 19
Testing effectiveness (Phase 2)Study completedNCT01468077
What this trial is testing

A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) Treatment

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 47
Not applicableWithdrawnNCT04388722
What this trial is testing

Monitoring Noninvasively for Infusion and Transfusion Optimization

Who this might be right for
Post Operative HemorrhageTransfusion Related ComplicationBlood Transfusion Associated Adverse Reactions+1 more
Masimo Corporation
Testing effectiveness (Phase 2)Study completedNCT00887341
What this trial is testing

A Study Comparing Infusion Rates of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 76
Large-scale testing (Phase 3)Study completedNCT00324298
What this trial is testing

Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganTesticular Germ Cell Tumor
Queen Mary University of London 210
Not applicableStudy completedNCT03526926
What this trial is testing

A Post-Marketing Observational Study of VYXEOS™

Who this might be right for
Acute Myeloid Leukemia With Myelodysplasia-Related ChangesTherapy-Related Acute Myeloid Leukemia
Jazz Pharmaceuticals 52
Not applicableLooking for participantsNCT07259291
What this trial is testing

Minto and Eleveld Remifentanil Target Controlled Infusion (TCI) Models: a Clinical Comparison

Who this might be right for
PropofolAnesthesia Brain MonitoringRemifentanil
University of Padova 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05663866
What this trial is testing

Premedication to Reduce Amivantamab Associated Infusion Related Reactions

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC 68
Testing effectiveness (Phase 2)Looking for participantsNCT01656603
What this trial is testing

Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

Who this might be right for
Infusion Reactions
New York Blood Center 9,999
Not applicableLooking for participantsNCT06839820
What this trial is testing

Infliximab Infusion Rates in Pediatric Inflammatory Bowel Disease

Who this might be right for
InfliximabInfusionIBD (Inflammatory Bowel Disease)+1 more
University Hospital, Akershus 60
Testing effectiveness (Phase 2)Study completedNCT04198623
What this trial is testing

Efficacy of Montelukast in Reducing the Incidence and Severity of Monoclonal Antibodies Associated Infusion Reactions

Who this might be right for
Infusion ReactionMonoclonal Antibody
University of California, San Francisco 40
Testing effectiveness (Phase 2)Study completedNCT01206777
What this trial is testing

Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell Malignancies

Who this might be right for
Indolent or Intermediate Grade B-cell Malignancy
Ohio State University Comprehensive Cancer Center 52
Post-approval studies (Phase 4)Study completedNCT00003252
What this trial is testing

Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Rush North Shore Medical Center
Not applicableUnknownNCT03420560
What this trial is testing

A Warmer Temperature Decrease Propofol Injection Pain

Who this might be right for
Injection Site IrritationPropofol SyndromeTemperature Change, Body
Xingui Dai 120
Not applicableUnknownNCT05801484
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Linezolid Continuous and Intermittent Administration

Who this might be right for
Side-effect of AntibioticEfficacyPharmacokinetics+2 more
Cluj Municipal Clinical Hospital 60
Not applicableStudy completedNCT00736333
What this trial is testing

Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED)

Who this might be right for
Breast Neoplasm
Merck Sharp & Dohme LLC 167
Post-approval studies (Phase 4)Study completedNCT02205489
What this trial is testing

Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADA

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Genzyme, a Sanofi Company 58
Not applicableStudy completedNCT04633967
What this trial is testing

Observational Study of a Novel Peri Infusion Regimen on the Infusion Associated Reactions With Alemtuzumab Infusion in Patients With Multiple Sclerosis in a Canadian Clinical Setting.

Who this might be right for
Frequency of Infusion Reactions in Novel Versus Standard Protocol in Multiple Sclerosis
Maritime Neurology 30
Early research (Phase 1)Study completedNCT04495478
What this trial is testing

Ramucirumab (LY3009806) in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 50
Not applicableStudy completedNCT04359368
What this trial is testing

Characteristics of Patients With Hypersensitivity Reactions to Intravenous Iron Infusions

Who this might be right for
Iron-deficiencyHypersensitivity Reactions
University Hospital, Basel, Switzerland 42
Load More Results